BC Advantage - 2025 Issue 5

AMA Announces New CPT® Category I Codes for Vaccines

The American Medical Association (AMA) has introduced five new Category I CPT® codes and revised one existing code for vaccine reporting. These updates - covering RSV, COVID-19 (SARS-CoV-2), and influenza - were approved by the CPT® Editorial Panel for the 2026 code set and will go into effect July 1, 2025.   What's New   For CPT® purposes, "immunization" encompasses vaccines/toxoids, immune globulins, serum, or recombinant products.   New Codes:   90382 – RSV, monoclonal antibody, seasonal dose (0.7 mL), intramuscular 91323 – COVID-19 (SARS-CoV-2) vaccine, mRNA-LNP, 10 mcg/0.2 mL, intramuscular 90635 – Influenza (H5N1), cell culture-derived...

To read the full article, sign in and subscribe to BC Advantage.

Access to this feature is available in the following products:
  • BC Advantage, 30+ CEUs & Webinars

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.